Expression of concern
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
Paper Information
Record ID:
35124
Author(s):
Journal:
Publication Date:
December 01, 2012
Retraction Date:
January 24, 2022
(3.8 years years ago)
Subjects:
Broad Categories:
Medicine
Medicine
Institutions:
- Department of Medicine 1, Agaplesion Markus Hospital, Wilhelm-Epstein-Str. 4, D-60431 Frankfurt/Main, Germany
- Division of Gastroenterology, Department of Medicine, MtSinai Hospital and University Health Network
- University of Toronto, 600 University Avenue, Toronto, ON, Canada
- M5G 1X5 and University of Leuven, Belgium
Countries:
Article Type:
Publisher:
Oxford Academic
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Expression of concern Details
Retraction Reasons:
Nature of Retraction:
Expression of concern
Retraction Notice:
10.1093/ecco-jcc/jjab227Additional Notes:
See also: https://doi.org/10.1093/ecco-jcc/jjab225 Journal was previously published by Elsevier until 2015.
Citations (1561)
1561
Total Citations239
Post-Retraction(15.3%)
1316
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
9
Within 30 days
111
Within 1 year
61
After 2+ years
1218
Days since retraction (latest)
Multifunctional hydrogels based on chitosan, hyaluronic acid and other biological macromolecules for the treatment of inflammatory bowel disease: A review
Yongliang Ouyang, Jiulong Zhao, Shige Wang
International Journal of Biological Macromolecules
Published: Dec 2022
95 citations
95 citations
318 days after retraction
The role and mechanism of flavonoid herbal natural products in ulcerative colitis
Jia-Chen Xue, Shuo Yuan, Huan Meng et al. (9 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: Dec 2022
72 citations
72 citations
318 days after retraction
Anti-inflammatory and antioxidant activity of astragalus polysaccharide in ulcerative colitis: A systematic review and meta-analysis of animal studies
Hengchang Hu, Wei Zhang, Peiyu Xiong et al. (6 authors)
Frontiers in Pharmacology
Open Access
Published: Dec 2022
27 citations
27 citations
312 days after retraction
The Effects of Multi-Donor Fecal Microbiota Transplantation Capsules Combined with Thalidomide on Hormone-Dependent Ulcerative Colitis
Xiaohe Guo, Yanli Zhu, Lu Yang et al. (5 authors)
Infection and Drug Resistance
Open Access
Published: Dec 2022
2 citations
2 citations
311 days after retraction
Economic impact of industry-sponsored clinical trials in inflammatory bowel diseases: Results from the national institute of gastroenterology “Saverio de Bellis”
Maurizio Polignano, Giuseppe Pasculli, Pietro Trisolini et al. (6 authors)
Frontiers in Pharmacology
Open Access
Published: Nov 2022
3 citations
3 citations
302 days after retraction
Integrated analysis of multiple microarray studies to establish differential diagnostic models of Crohn’s disease and ulcerative colitis based on a metalloproteinase-associated module
Jiang Deng, Ning Zhao, Li‐Ping Lv et al. (9 authors)
Frontiers in Immunology
Open Access
Published: Nov 2022
3 citations
3 citations
301 days after retraction
Acute Severe Ulcerative Colitis: Optimal Strategies for Drug Therapy
Hiroshi Nakase
Gut and Liver
Open Access
Published: Nov 2022
22 citations
22 citations
294 days after retraction
Investigating dysbiosis and microbial treatment strategies in inflammatory bowel disease based on two modified Koch’s postulates
HanZheng Zhao, Wenhui Zhang, Die Cheng et al. (6 authors)
Frontiers in Medicine
Open Access
Published: Nov 2022
10 citations
10 citations
290 days after retraction
Significance of 5-Aminosalicylic Acid Intolerance in the Clinical Management of Ulcerative Colitis
Yohei Mikami, Junya Tsunoda, S Suzuki et al. (6 authors)
Digestion
Open Access
Published: Nov 2022
39 citations
39 citations
290 days after retraction
Budget impact analysis of the subcutaneous infliximab (CT-P13 SC) for treating inflammatory bowel disease in the Big-5 European (E5) countries
Hyun Kyeong Yoo, Han Geul Byun, Flavio Caprioli et al. (8 authors)
BMC Health Services Research
Open Access
Published: Nov 2022
11 citations
11 citations
284 days after retraction
Nicotinamide adenine dinucleotide metabolism: driving or counterbalancing inflammatory bowel disease?
Xinru Xue, Yumeng Miao, Zhifeng Wei
FEBS Letters
Open Access
Published: Oct 2022
9 citations
9 citations
280 days after retraction
Steroid Resistance/Dependence Might Be an Alarming Feature for Cytomegalovirus Infection Among Ulcerative Colitis Patients With Increased Disease Activity
Emre Gerçeker, Fatih Saygılı, Arzu Avcı et al. (4 authors)
Cureus
Open Access
Published: Oct 2022
3 citations
3 citations
279 days after retraction
Regulation of Yujin Powder alcoholic extracts on ILC3s-TD IgA-colonic mucosal flora axis of DSS-induced ulcerative colitis
Yanqiao Wen, Wangdong Zhang, Rong Yang et al. (11 authors)
Frontiers in Microbiology
Open Access
Published: Oct 2022
4 citations
4 citations
269 days after retraction
Postcolectomy Enteritis in a Pediatric Patient With Ulcerative Colitis
Kathryn Hawa, Ross Maltz, Amy Donegan et al. (7 authors)
JPGN Reports
Open Access
Published: Oct 2022
269 days after retraction
Ulcerative colitis progression: a retrospective analysis of disease burden using electronic medical records
David Dahlgren, Lars Agréus, Jan Stålhammar et al. (4 authors)
Upsala Journal of Medical Sciences
Open Access
Published: Oct 2022
3 citations
3 citations
267 days after retraction
Mesalazine in the induction of clinical and endoscopic remission of mild and moderate ulcerative colitis
М. В. Шапина
Meditsinskiy sovet = Medical Council
Open Access
Published: Oct 2022
2 citations
2 citations
255 days after retraction
Hyaluronic Acid-Conjugated PLGA Nanoparticles Alleviate Ulcerative Colitis via CD44-Mediated Dual Targeting to Inflamed Colitis Tissue and Macrophages
Shwe Phyu Hlaing, Jiafu Cao, Juho Lee et al. (12 authors)
Pharmaceutics
Open Access
Published: Oct 2022
26 citations
26 citations
254 days after retraction
Hedysarum multijugum Maxim treats ulcerative colitis through the PI3K-AKT and TNF signaling pathway according to network pharmacology and molecular docking
Zihao Zhang, Wei Chong, Xiaozhou Xie et al. (6 authors)
Annals of Translational Medicine
Open Access
Published: Oct 2022
10 citations
10 citations
250 days after retraction
From Hair to Colon: Hair Follicle-Derived MSCs Alleviate Pyroptosis in DSS-Induced Ulcerative Colitis by Releasing Exosomes in a Paracrine Manner
Yuan Chang, Yichi Zhang, Yanan Jiang et al. (8 authors)
Oxidative Medicine and Cellular Longevity
Open Access
Published: Sep 2022
12 citations
12 citations
235 days after retraction
An Extremes of Phenotype Approach Confirms Significant Genetic Heterogeneity in Patients with Ulcerative Colitis
Sally Mortlock, Anton Lord, Grant W. Montgomery et al. (20 authors)
Journal of Crohn s and Colitis
Open Access
Published: Sep 2022
6 citations
6 citations
235 days after retraction
Analysis of clinical characteristics of mesalazine-induced cardiotoxicity
Junyu Chen, Tengfei Duan, Weijin Fang et al. (5 authors)
Frontiers in Pharmacology
Open Access
Published: Sep 2022
7 citations
7 citations
234 days after retraction
Pathogenesis, diagnosis, dietary management, and prevention of gastrointestinal disorders in the paediatric population
Giulio Pulvirenti, Vincenzo Sortino, Sara Manti et al. (7 authors)
The Italian Journal of Pediatrics/Italian journal of pediatrics
Open Access
Published: Sep 2022
3 citations
3 citations
230 days after retraction
Basic practices for gastrointestinal ultrasound
Mutsumi Nishida, Yuichi Hasegawa, Jiro Hata
Journal of Medical Ultrasonics
Open Access
Published: Sep 2022
9 citations
9 citations
229 days after retraction
Impact of COVID-19 Pandemic on Initiation of Immunosuppressive Treatment in Immune-Mediated Inflammatory Diseases in Austria: A Nationwide Retrospective Study
Maximilian Kutschera, Valentin Ritschl, Berthold Reichardt et al. (9 authors)
Journal of Clinical Medicine
Open Access
Published: Sep 2022
3 citations
3 citations
228 days after retraction
Trends and Demographic Patterns in Biologic and Corticosteroid Prescriptions for Inflammatory Bowel Disease: Findings from Electronic Medical Records, 2011–2020
Fang Xü, Yong Liu, Kurt J. Greenlund et al. (4 authors)
Journal of Investigative Medicine
Open Access
Published: Sep 2022
2 citations
2 citations
224 days after retraction
Targeting Lineage-Specific Transcription Factors and Cytokines of the Th17/Treg Axis by Novel 1,3,4-Oxadiazole Derivatives of Pyrrolo[3,4-d]pyridazinone Attenuates TNBS-Induced Experimental Colitis
Marta Szandruk-Bender, Benita Wiatrak, S. Dzimira et al. (7 authors)
International Journal of Molecular Sciences
Open Access
Published: Aug 2022
9 citations
9 citations
219 days after retraction
Thiopurine S-Methyltransferase Polymorphisms Predict Hepatotoxicity in Azathioprine-Treated Patients with Autoimmune Diseases
Heh-Shiang Sheu, Yi‐Ming Chen, Yi‐Ju Liao et al. (9 authors)
Journal of Personalized Medicine
Open Access
Published: Aug 2022
7 citations
7 citations
216 days after retraction
Corticosteroid-Sparing Effects of Filgotinib in Moderately to Severely Active Ulcerative Colitis: Data from the Phase 2b/3 SELECTION Study
Edward V. Loftus, Séverine Vermeire, Brian G. Feagan et al. (8 authors)
Journal of Crohn s and Colitis
Open Access
Published: Aug 2022
10 citations
10 citations
212 days after retraction
Analysis of the initial dose and reduction rate of corticosteroid for ulcerative colitis in clinical practice
Masataka Masuda, Norimasa Fukata, Yasuki Sano et al. (10 authors)
JGH Open
Open Access
Published: Aug 2022
9 citations
9 citations
208 days after retraction
Probiotic supplementation induces remission and changes in the immunoglobulins and inflammatory response in active ulcerative colitis patients: A pilot, randomized, double-blind, placebo-controlled study
Lana M. Agraib, Mohammed I. Yamani, Reema Tayyem et al. (5 authors)
Clinical Nutrition ESPEN
Published: Aug 2022
26 citations
26 citations
208 days after retraction
Fecal microbiota transplantation versus glucocorticoids for the induction of remission in mild to moderate ulcerative colitis
Chunlan Huang, Zehua Huang, Ling Ding et al. (12 authors)
Journal of Translational Medicine
Open Access
Published: Aug 2022
24 citations
24 citations
200 days after retraction
Trends in medication use and treatment patterns in Chinese patients with inflammatory bowel disease
Lingya Yao, Bule Shao, Feng Tian et al. (14 authors)
World Journal of Gastroenterology
Open Access
Published: Aug 2022
13 citations
13 citations
197 days after retraction
Adalimumab biosimilars in the therapy of Crohn´s disease and ulcerative colitis: Prospective multicentric clinical monitoring
Martin Wasserbauer, Štěpán Hlava, Jir̆ı́ Drábek et al. (17 authors)
PLoS ONE
Open Access
Published: Aug 2022
9 citations
9 citations
196 days after retraction
Utilization of Colonoscopy Following Treatment Initiation in U.S. Commercially Insured Patients With Inflammatory Bowel Disease, 2013-2019
Jeff Y. Yang, Jennifer L. Lund, Virginia Pate et al. (4 authors)
Inflammatory Bowel Diseases
Open Access
Published: Aug 2022
10 citations
10 citations
193 days after retraction
Store‐operated calcium entry controls innate and adaptive immune cell function in inflammatory bowel disease
Marilena Letizia, Yin‐Hu Wang, Ulrike Kaufmann et al. (20 authors)
EMBO Molecular Medicine
Open Access
Published: Aug 2022
34 citations
34 citations
190 days after retraction
<i>Campylobacter jejuni</i>pancolitis complicated by toxic megacolon in an immunocompetent host
Syed Wajih Ul Hassan, Sheena Nadeem Alam, Nazar Ulla Syed et al. (4 authors)
BMJ Case Reports
Open Access
Published: Aug 2022
3 citations
3 citations
189 days after retraction
The emerging microbiome‐based approaches to <scp>IBD</scp> therapy: From <scp>SCFAs</scp> to urolithin A
Mohammad Rudiansyah, Saade Abdalkareem Jasim, Bakhadir S. Azizov et al. (12 authors)
Journal of Digestive Diseases
Published: Aug 2022
10 citations
10 citations
189 days after retraction
Cholesterol sulfate alleviates ulcerative colitis by promoting cholesterol biosynthesis in colonic epithelial cells
Dongke Xu, Rui-Jun Ma, Yi Ju et al. (15 authors)
Nature Communications
Open Access
Published: Jul 2022
51 citations
51 citations
187 days after retraction
Update on gut microbiota in gastrointestinal diseases
Atsushi Nishida, Kyohei Nishino, Masashi Ohno et al. (7 authors)
World Journal of Clinical Cases
Open Access
Published: Jul 2022
15 citations
15 citations
179 days after retraction
Beliefs About Medicines and Adherence to Treatment in Turkish Patients with Inflammatory Bowel Disease
Güray Can, Ahmet Yozgat, Ahmet Tezel et al. (5 authors)
The Turkish Journal of Gastroenterology
Open Access
Published: Jul 2022
3 citations
3 citations
176 days after retraction
Real-World Effectiveness of Vedolizumab Dose Escalation in Patients With Inflammatory Bowel Disease: A Systematic Literature Review
Dipen Patel, Stéphan Martin, Michelle Luo et al. (7 authors)
Crohn s & Colitis 360
Open Access
Published: Jul 2022
4 citations
4 citations
158 days after retraction
The Risk of Serious Infections Before and After Anti-TNF Therapy in Inflammatory Bowel Disease: A Retrospective Cohort Study
Johanna Holmgren, Anna Fröborg, Isabella Visuri et al. (23 authors)
Inflammatory Bowel Diseases
Open Access
Published: Jul 2022
5 citations
5 citations
158 days after retraction
Overweight and abdominal fat are associated with normal bone mineral density in patients with ulcerative colitis
Mirella Brasil Lopes, André Castro Lyra, Raquel Rocha et al. (7 authors)
World Journal of Gastrointestinal Pharmacology and Therapeutics
Open Access
Published: Jun 2022
1 citation
1 citation
156 days after retraction
Inflammatory Bowel Disease Treatments and Predictive Biomarkers of Therapeutic Response
Duaa Ahmed Elhag, Manoj Kumar, Marwa Saadaoui et al. (7 authors)
International Journal of Molecular Sciences
Open Access
Published: Jun 2022
85 citations
85 citations
150 days after retraction
Oral beclomethasone dipropionate as an add-on therapy and response prediction in Korean patients with ulcerative colitis
Kyuwon Kim, Hee Seung Hong, Kyunghwan Oh et al. (13 authors)
The Korean Journal of Internal Medicine
Open Access
Published: Jun 2022
149 days after retraction
State-of-the-art surgery for Crohn’s disease: Part II—colonic Crohn’s disease and associated neoplasms
Anne Macleod, Sandra L. Kavalukas, Katharina M. Scheurlen et al. (4 authors)
Langenbeck s Archives of Surgery
Published: Jun 2022
6 citations
6 citations
149 days after retraction
The Distinguishing Bacterial Features From Active and Remission Stages of Ulcerative Colitis Revealed by Paired Fecal Metagenomes
Ran Zhu, Junrui Tang, Chengfeng Xing et al. (11 authors)
Frontiers in Microbiology
Open Access
Published: Jun 2022
5 citations
5 citations
148 days after retraction
Novel Budesonide Suppository and Standard Budesonide Rectal Foam Induce High Rates of Clinical Remission and Mucosal Healing in Active Ulcerative Proctitis: a Randomised, Controlled, Non-inferiority Trial
Wolfgang Kruis, Britta Siegmund, Konrad Leśniakowski et al. (28 authors)
Journal of Crohn s and Colitis
Open Access
Published: Jun 2022
10 citations
10 citations
143 days after retraction
Memory T Cell Subpopulations as Early Predictors of Remission to Vedolizumab in Ulcerative Colitis
M González-Vivó, Minna K. Lund Tiirikainen, Montserrat Andreu et al. (12 authors)
Frontiers in Medicine
Open Access
Published: Jun 2022
5 citations
5 citations
142 days after retraction
Management of Non-response and Loss of Response to Anti-tumor Necrosis Factor Therapy in Inflammatory Bowel Disease
Jan Marsal, Manuel Barreiro‐de Acosta, Irina Blumenstein et al. (6 authors)
Frontiers in Medicine
Open Access
Published: Jun 2022
57 citations
57 citations
142 days after retraction
Quick Stats
Total Citations:
1561
Years Since Retraction:
3.8 years
Open Access:
Yes
Last Checked:
Jul 24, 2025